The Callodine Group’s investing arm, Callodine Capital Management, was created by James Morrow. Morrow holds an MBA from the University of Chicago Booth School of Business and has an excellent academic background. He previously spent over two decades as a Portfolio Manager at Fidelity Investments. Callodine Capital is primarily interested in dividend-paying stocks. A high dividend yield, according to the business, should be matched with excellent valuations. Callodine employs long/short, long-only, and sector-focused strategies to manage investment. The equity portfolio was valued at $265 million in the second quarter of 2021. Citigroup Inc. is owned by Callodine Capital, which has a significant investment in the company. Callodine’s portfolio includes 1.87 percent of the New York-based financial services firm. The corporation has 70,000 shares worth roughly $5 million in market value. With a market value of $18.54 million, Callodine Capital owns 277,500 shares of Bristol-Myers Squibb Company. The US Department of Labor has awarded the business five network upgrade task orders totaling $887 million.
Insider Monkey picked the top 10 stocks from the second quarter portfolio of James Morrow’s Callodine Capital. Equitable Holdings, Inc. offers a wide range of financial services, including individual, group, and life insurance products, as well as investment research and management. Since the first quarter of 2021, Callodine Capital’s investment portfolio has included shares of the New York-based corporation. Gilead Sciences, Inc. is a biopharmaceutical business situated in Foster City, California. The firm has been in the news recently due to the exorbitant cost of its breakthrough medicine Sovaldi, which is used to treat hepatitis C. Following the combination of Upjohn and Mylan in November 2020, Viatris Inc. was formed. Hedge fund confidence has recently dipped at the company. Viatris was held by 53 of the 873 funds monitored by Insider Monkey at the end of the second quarter. PennantPark Investment Corporation is a publicly traded business that provides middle market credit exposure to clients via various investment vehicles. The firm, created in 2007, specializes in debt financing for middle-market companies with EBITDA of $10 million to $50 million. Wells Fargo & Company is owned by Callodine Capital, which holds 225,000 shares. The stock’s weighting in James Morrow’s portfolio has remained unchanged during the previous quarter. The San Francisco-based financial services firm has $1.9 trillion in assets and is connected to one out of every three households. For more details, click 10 Stock Picks Of James Morrow’s Callodine Capital.
Unsplash
